<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01740453</url>
  </required_header>
  <id_info>
    <org_study_id>KTBIS-2012-V1</org_study_id>
    <nct_id>NCT01740453</nct_id>
  </id_info>
  <brief_title>Effect of Interscalene Block on Ventilatory Function</brief_title>
  <acronym>KTBIS</acronym>
  <official_title>Interscalene Block on Ventilatory Function After Shoulder Surgery : Evaluation of Single or Continuous Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pierre and Marie Curie University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pierre and Marie Curie University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interscalene block with local anesthetic impairs ventilation (unilateral diaphragmatic
      dysfunction). Single injection of local anesthetic induced transitory dysfunction (&lt; 24h).
      The investigators hypothesized that continuous interscalene block would prolonged ventilatory
      impairment
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Unilateral pulmonary dysfunction occured after interscalene block due to phrenic nerve
      paralysis. This reduction induced vital capacity alteration and peek flow reduction.Several
      studies analysed dysfunction recovery duration after single injection using short
      (lidocaine)or intermediate (ropivacaine, bupivacaine)local anesthetic drug. Because
      continuous infusion prolonged block duration, phenic nerve may be also prolonged. However no
      study with continuous interscalene infusion have been performed for this dysfunction.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of the pulmonary forced vital capacity</measure>
    <time_frame>Day 2</time_frame>
    <description>A 25 % reduction of the pulmonary forced vital capacity is expected and measured using spirometer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of the pulmonary maximum forced expiratory flow</measure>
    <time_frame>Day 2</time_frame>
    <description>Outcome measure was performed using a spirometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morphine consumption</measure>
    <time_frame>Day 2</time_frame>
    <description>Additional morphine administration for pain management (morphine intravenous : 1 mg every 7 min when necessary, pain score &gt; 3/10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score at rest and motion</measure>
    <time_frame>Day 2</time_frame>
    <description>Outcome Measure using a visual analog scale (0 to 10)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Duration of sensory interscalene block</measure>
    <time_frame>Day 2</time_frame>
    <description>outcome measure was performed using a cold test on the skin</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Respiratory Depression</condition>
  <condition>Anesthesia Morbidity</condition>
  <condition>Block</condition>
  <arm_group>
    <arm_group_label>Single (no catheter)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>ropivacaine single injection : 5 mg/ml 15 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single injection with continuous injection ropivacaine 2 mg/ml 8 ml/h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine 2 mg/ml</intervention_name>
    <description>single</description>
    <arm_group_label>Continuous infusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  surgery : scheduled for elective shoulder surgery

          -  available for 1 month of follow up

          -  physical status : 1, 2, 3

        Exclusion Criteria:

          -  body mass index &gt; 35

          -  contraindication for interscalene block (local sepsis, bleeding, allergy, peripheral
             neuropathy)

          -  vital capacity less than 1.5 liters

          -  cardiac or renal insufficiency

          -  physical status &gt;3, pregnant, weigh less than 50 kg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Cuvillon, Md,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Caremeau Hospital, Nimes, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre hospitalier La Pitié Salpetriere</name>
      <address>
        <city>Paris</city>
        <state>Ile de France</state>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2012</study_first_submitted>
  <study_first_submitted_qc>November 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2012</study_first_posted>
  <last_update_submitted>January 16, 2015</last_update_submitted>
  <last_update_submitted_qc>January 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire de Nīmes</investigator_affiliation>
    <investigator_full_name>Philippe Cuvillon</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

